4/26/08

The characteristics of Chinese medicine treatment of diabetic

Since the founding of new China, Chinese medicine and Western medicine in the prevention and treatment of diabetes has made remarkable achievements: the level of development from cell to the molecular level enzymology, molecular biology level of study range from simple development Antidiabetic to lower blood lipids, improve microcirculation And so on. Although the new oral hypoglycemic agents continue to emerge, widely used in clinical insulin, but the combination therapy in Chinese medicine for the treatment of diabetes and its complications, to effect stability, non-toxic side effects, regulating the body of the environment, improve physical fitness, reduce insulin resistance, Regulating glucose and lipid metabolism, enhance the stability of sugar since the advantages in light and medium-sized diabetes prevention and treatment work in the possession of certain advantages, especially for treatment of complications of diabetes significantly. With the development of modern science and technology and their mutual penetration in the medical, pharmaceutical treatment of diabetes in the study of mechanisms have made gratifying achievements, Henan Rehabilitation Centre Hospital Diabetes Research Center for "certification" in-depth study, the establishment of a "dialectical objective." "Quantitative diagnosis," "Syndromes of standardization" and objective indicators such as the relevance system so that diabetes in Integrative Medicine study into a higher level, from the clinical practice of screening a group of reliable efficacy of herbs, both in breadth and depth of Both reached a new level, Chinese medicine for diabetes prevention and treatment to the world, and the World Medical convergence laid a good foundation.

Disadvantages: hypoglycemic effect slowly, at home and abroad can not work out within two weeks of pure Chinese medicine hypoglycemic soon on the market who can quickly separate the so-called hypoglycemic pure Chinese medicine is generally a plus.

No comments: